文献速递物质与行为成瘾会诊联络精神医学

HIV背景下单细胞阿片类药物反应(SCORCH)联盟

The single-cell opioid responses in the context of HIV (SCORCH) consortium.
PubMed 文献 · Mol Psychiatry · 2024-06-15

作者假设两者对脑细胞类型有共同效应,拟用单细胞基因组学整合人脑组织与动物模型数据加以刻画。

要点

  • HIV者的慢性疼痛综合征可增加阿片类镇痛药使用,从而增加阿片成瘾风险。
  • SCORCH联盟拟用单细胞基因组学整合人脑队列与动物模型数据。

核心结论

  • 作者假设物质使用障碍与HIV对脑细胞类型 exert 共同效应,涉及神经可塑性、神经退行性和神经炎症相关适应。
  • 作者提出单细胞基因组学是刻画物质使用障碍与HIV脑内效应的独特有力技术,可整合人队列与动物模型数据。
  • 为实施该策略,已成立HIV背景下单细胞阿片类药物反应(SCORCH)联盟。

研究设计与样本

  • 本文为联盟介绍性文章,提出研究策略并宣布成立SCORCH联盟。
  • 策略依托Neuro-HIV研究社区积累的大规模、表型详尽的人脑组织采集库及两种状况的精细动物模型。

主要发现

  • HIV者的慢性疼痛综合征常导致阿片类镇痛药使用增加,进而增加阿片成瘾风险。
  • 物质使用障碍与HIV可能对脑细胞类型产生共同效应,涉及神经可塑性、神经退行性和神经炎症相关适应。
  • 单细胞水平研究物质使用障碍在HIV背景下的效应,是理解两种状况相互作用的可行策略。

临床怎么用

  • 作者提出单细胞基因组学可整合人队列与动物模型数据,用于刻画物质使用障碍与HIV的脑内效应。
  • 作者认为需开展基础研究以细化对受累细胞类型及适应的理解。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Substance use disorders (SUD) and drug addiction are major threats to public health, impacting not only the millions of individuals struggling with SUD, but also surrounding families and communities. One of the seminal challenges in treating and studying addiction in human populations is the high prevalence of co-morbid conditions, including an increased risk of contracting a human immunodeficiency virus (HIV) infection. Of the ~15 million people who inject drugs globally, 17% are persons with HIV. Conversely, HIV is a risk factor for SUD because chronic pain syndromes, often encountered in persons with HIV, can lead to an increased use of opioid pain medications that in turn can increase the risk for opioid addiction. We hypothesize that SUD and HIV exert shared effects on brain cell types, including adaptations related to neuroplasticity, neurodegeneration, and neuroinflammation. Basic research is needed to refine our understanding of these affected cell types and adaptations. Studying the effects of SUD in the context of HIV at the single-cell level represents a compelling strategy to understand the reciprocal interactions among both conditions, made feasible by the availability of large, extensively-phenotyped human brain tissue collections that have been amassed by the Neuro-HIV research community. In addition, sophisticated animal models that have been developed for both conditions provide a means to precisely evaluate specific exposures and stages of disease. We propose that single-cell genomics is a uniquely powerful technology to characterize the effects of SUD and HIV in the brain, integrating data from human cohorts and animal models. We have formed the Single-Cell Opioid Responses in the Context of HIV (SCORCH) consortium to carry out this strategy.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ament SA, Campbell RR, Lobo MK, et al. The single-cell opioid responses in the context of HIV (SCORCH) consortium. Mol Psychiatry. 2024. PMID: 38879719. doi:10.1038/s41380-024-02620-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。